Advanced Anemia Management for Hemodialysis Patients: A Novel Approach in Clinical Practice
April 15, 2020 - Postponed
12:00 PM - 1:00 PM ET
Join us to hear about clinical data and practical experiences with use of a maintenance iron replacement therapy.
Chronic hemodialysis patients lose approximately 5–7 mg of iron at every hemodialysis treatment.1
The goal of iron maintenance is to replace lost iron, maintain hemoglobin levels, and avoid overloading iron stores.2,3
This can be achieved by providing bioavailable iron, which is critical for the hemodialysis-dependent chronic kidney disease (HDD-CKD) patient.4
Hear from experts about practical applications of a novel physiological approach in iron maintenance that delivers 100% bioavailable iron resulting in hemoglobin stability.5,6
During this time, we understand your top priority is with your patients and we will be postponing the RSE Industry Spotlight webinar, sponsored by Rockwell Medical. This webinar was originally scheduled for April 15, 2020 and will be postponed until June 2020.
Registration will be paused at this time. A new date and time will be communicated in the coming weeks.
(March 26, 2020)
*Non NRAA Members have access to NRAA Education Station (online courses,) but may pay a higher fee per course and are required to register as a Webinar Attendee first. Webinar Attendees do not receive member pricing for courses or any other NRAA Member Benefits.
To join as a NRAA Member or as a Webinar Attendee, click here.
1. Gupta A, et al. Kidney Int. 2015;88(5):1187-11942. KDIGO Anemia Work Group. Kidney Int. 2012;2(4):279-335.3. Rostoker G, et al. Drugs. 2016;76(7):741-757.4. Varziri ND, et al. Am J Kidney Dis. 2016;67(3):367-375.5. Pratt RD, et al. J Clin Pharmacol. 2017;57(3):312-320.6. Fishbane SN, et al. Nephrol Dial Transplant. 2015;30(12):2019-2026.